Neurology·New Haven, CT

Yale-New Haven Medical Center

Signal lift35%80%+45 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
238–268
p10 – p90
Sample N
722
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.7%
12 of 161 applicants
01Cohort funnelthis cycle
N = 722
Applied
722
100.0%
Invited
161
22.3%
Class size
12
1.7%
J-1 visaH-1B visaF-1 visaAdvancedResearchAcademic/Clinician Educator
Your fitYale-New Haven Medical Center Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at Yale-New Haven Medical Center Program

Create free account
Contact
SS
Program Director
Sara Schaefer, MD
Email director
JM
Program Coordinator
Jeremy Moeller, MD, MSc
Email coordinator
Training sites2 hospitals
  • 1
    Yale-New Haven Hospital
    New Haven, CT
    Primary
  • 2
    VA Connecticut Healthcare System (West Haven)
    West Haven, CT
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK238268
180205230255280

Level 2 CE data not available

Interview rates
US MD
41%
US DO
2%
US IMG
5%
Non-US IMG
5%
Applicant origin
In-state
55%
Out-of-state
22%
Interview prepNeurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesNeurology · 25-26
Save this program

Add Yale-New Haven Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Neurology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.